Centre Hospitalier Universitaire
Rennes, 35033, France
NCT Number: NCT02492529
Unrandomized, unblinded, monocentric comparative Functional Magnetic Resonance Imaging study.
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Not applicable
Rennes, 35033, France
Prospective functional Magnetic Resonance Imaging study involving a group of participants with Mild Cognitive Impairment due to AD and a control participants group matched for age, education level, verbal Intelligence Quotient as assessed through the French version of the National Adult Reading Test and income group following National Institute of Statistics and Economics Studies classification.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Volunteers (pilot phase)
Volunteers (experimental phase)
AD-MCI participants
Exclusion criteria
MRI contraindications (all participants)
Other criteria (all participants)
Other criteria (control participants)
Other criteria (AD-MCI participants)
Scales and tests to evaluate:
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Rennes University Hospital
Other
Acronym: EPMR-MA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05463731
Alzheimer Disease, Alzheimer's Disease
Chandler, Arizona, United States
View Trial DetailsNCT04073628
Alzheimer Disease, Alzheimer's Disease
Albany, New York, United States
View Trial DetailsNCT00647478
Alzheimer Disease, Alzheimer's Disease
Paris, France
View Trial DetailsNCT06595030
Alzheimer Disease, Alzheimer's Disease
Menands, New York, United States
View Trial Details